Home/ Stocks/ STOK

Stoke Therapeutics, Inc. Common Stock

STOK XNAS

$32.89 +0.10 (+0.30%) ▲ 15-min delayed

Open

$31.92

High

$33.29

Low

$31.28

Volume

693.1K

Market Cap

$2.05B

About Stoke Therapeutics, Inc. Common Stock

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the bodys potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Sector: PHARMACEUTICAL PREPARATIONS Employees: 170 Website →

Key Financials

Period	Revenue	Net Income	EPS
Q1 2026	$6.23M	$-50,003,000	$-0.79
FY 2025	$184.42M	$-6,885,000	$-0.12
Q3 2025	$10.63M	$-38,347,000	$-0.65
Q2 2025	$13.82M	$-23,483,000	$-0.40

Related Market News

No specific coverage for STOK yet. Check out our latest market news or earnings calendar.

Get STOK Alerts

Stay ahead with breaking news, price alerts, and expert analysis on Stoke Therapeutics, Inc. Common Stock.

Disclaimer: This page is for informational purposes only. Stock data is delayed by at least 15 minutes. Always conduct your own research and consult with a qualified financial advisor before making investment decisions.